Related references
Note: Only part of the references are listed.Molecular Pathophysiology and Disease-Modifying Therapies for Spinal and Bulbar Muscular Atrophy
Masahisa Katsuno et al.
ARCHIVES OF NEUROLOGY (2012)
Difference in chronological changes of outcome measures between untreated and placebo-treated patients of spinal and bulbar muscular atrophy
Atsushi Hashizume et al.
JOURNAL OF NEUROLOGY (2012)
The Possible Structural Models for Polyglutamine Aggregation: A Molecular Dynamics Simulations Study
Zheng-Li Zhou et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2011)
Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial
Lindsay E. Fernandez-Rhodes et al.
LANCET NEUROLOGY (2011)
CAG Repeats Determine Brain Atrophy in Spinocerebellar Ataxia 17: A VBM Study
Kathrin Reetz et al.
PLOS ONE (2011)
Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial
Masahisa Katsuno et al.
LANCET NEUROLOGY (2010)
Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy
J. Montes et al.
NEUROLOGY (2010)
The propagation of prion-like protein inclusions in neurodegenerative diseases
Michel Goedert et al.
TRENDS IN NEUROSCIENCES (2010)
Phase 2 Trial of Leuprorelin in Patients with Spinal and Bulbar Muscular Atrophy
Haruhiko Banno et al.
ANNALS OF NEUROLOGY (2009)
Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study
R. Nandhagopal et al.
BRAIN (2009)
Clinical features of spinal and bulbar muscular atrophy
Lindsay E. Rhodes et al.
BRAIN (2009)
Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data
Sarah J. Tabrizi et al.
LANCET NEUROLOGY (2009)
UTILITY OF CYSTATIN C TO MONITOR RENAL FUNCTION IN DUCHENNE MUSCULAR DYSTROPHY
Laurence Viollet et al.
MUSCLE & NERVE (2009)
SERUM CREATINE KINASE LEVELS IN SPINOBULBAR MUSCULAR ATROPHY AND AMYOTROPHIC LATERAL SCLEROSIS
Nizar Chahin et al.
MUSCLE & NERVE (2009)
Disease-modification trials in Parkinson disease: Target populations, endpoints and study design
Olivier Rascol
NEUROLOGY (2009)
Treatment of vascular risk factors is associated with slower decline in Alzheimer disease
Yan Deschaintre et al.
NEUROLOGY (2009)
Spinal and bulbar muscular atrophy:: Skeletal muscle pathology in male patients and heterozygous females
Gianni Soraru et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy
Yu Takeuchi et al.
MUSCLE & NERVE (2008)
Alzheimer's disease - Moving towards a vaccine
David M. Holtzman
NATURE (2008)
Onset and progression in inherited ALS determined by motor neurons and microglia
Severine Boillee et al.
SCIENCE (2006)
Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients
Naoki Atsuta et al.
BRAIN (2006)
Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: A pathogenic marker
H Banno et al.
ANNALS OF NEUROLOGY (2006)
Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism
DR Williams et al.
BRAIN (2005)
Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy
ES Chevalier-Larsen et al.
JOURNAL OF NEUROSCIENCE (2004)
Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy
M Katsuno et al.
NATURE MEDICINE (2003)
Mechanisms of disease: Apoptosis and caspases in neurodegenerative diseases
RM Friedlander
NEW ENGLAND JOURNAL OF MEDICINE (2003)
X-linked bulbospinal neuronopathy -: Kennedy disease
AD Sperfeld et al.
ARCHIVES OF NEUROLOGY (2002)
Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women
BJ Schmidt et al.
NEUROLOGY (2002)
Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy
M Katsuno et al.
NEURON (2002)
Reduced item set for the amyotrophic lateral sclerosis assessment questionnaire: development and validation of the ALSAQ-5
C Jenkinson et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Clinical and molecular advances in autosomal dominant cerebellar ataxias: from genotype to phenotype and physiopathology
G Stevanin et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2000)
Share Paper
